Arsenal continues interest in Newcastle defender Tino Livramento
Yahoo Sports • 1 min read • Latest: Nov 6, 2026, 12:00 PM
Last updated Nov 6, 2026

Arsenal remains interested in Newcastle United defender Tino Livramento, despite concerns over his injury history. Livramento, regarded as one of the top full-backs in the Premier League when healthy, has been closely monitored by Arsenal for some time. While the Gunners' pursuit appeared to slow due to Livramento's recurring fitness issues, they may explore a move sooner than expected. Newcastle's potential demands for a substantial transfer fee could impact Arsenal's approach, particularly regarding Livramento's ability to stay fit and contribute consistently.
- •Arsenal has tracked Tino Livramento for an extended period.
- •Livramento has faced injury problems affecting his playtime.
- •Newcastle is expected to demand a significant fee for Livramento.
- •Arsenal appreciates Livramento's quality and potential impact on their squad.
- •Any transfer depends on Livramento's fitness and health status.
- 12:00 PMYahoo Sports — Arsenal is still tracking Newcastle United defender
"Tino Livramento has been on Arsenal’s radar for some time, although their interest appeared to have cooled in recent months as the Newcastle United defender continued to struggle with injury problem...
Sources
External linksOriginal reporting and copyright belong to the linked sources. SportsNewsReport.com aggregates and links — it does not republish full articles.
Related Stories
Last 14 days- EPL•Nov 6, 2026, 1:19 PMPremier League latest: Maresca on Foden's England omission; Arbeloa on King call-up
EPL•Nov 6, 2026, 12:16 PMHas Anderson lived up to the hype after Man City move?
EPL•Nov 6, 2026, 11:38 AMWhy Sheridan volleyball's fast start wasn't enough vs. Bloom-Carroll
EPL•Nov 6, 2026, 11:18 AMAmar Dedic set to escape Newcastle sanction over carrying bow and arrow
EPL•Nov 6, 2026, 10:41 AMJude's brother Jobe Bellingham gets England call-up
EPL•Nov 6, 2026, 10:33 AMBellingham and King handed England call-up, but Palmer overlooked
